Skip to main content
    P

    Pharming Group NV (PHAR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $12.06
    -0.53 (-4.21%)

    Market Cap: $891.80M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Pharming Group NV (PHAR) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Pharming Group NV (PHAR) has a latest price of $12.06 on Nov 17, 2026, 43.5% below its 52-week high of $21.34. Its price fell 28.3% over the past 12 months. The month-end price rose 35.9% over the 5 years through Oct 2026, a compound annual rate of 6.3%.

    Price Chart

    From Dec 2020 to Oct 2026, its highest month-end close was $20.47 in Jan 2026 and its lowest $7.35 in Nov 2024, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart PHAR with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PHAR.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 1.8%, and over 6 months it fell 4.3%. The month-end price rose 3.1% over the 3 years through Oct 2026, a compound annual rate of 1.0%.

    PeriodChange
    1 month+32.4%
    3 months+1.8%
    6 months-4.3%
    12 months-28.3%
    12 months, with dividends-28.3%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+3.1%+1.0%
    5 years+35.9%+6.3%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 75.6%, and its weakest was 2021, when it fell 41.2%.

    YearCloseChange
    2026 through Oct 2026$12.23-30.8%
    2025$17.67+75.6%
    2024$10.06-11.9%
    2023$11.43+3.6%
    2022$11.03+23.4%
    2021$8.94-41.2%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 9.7% above its 50-day average of $11.00 and 9.9% below its 200-day average of $13.38.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$12.06
    52-week high$21.34-43.5%
    52-week low$9.11+32.4%
    50-day average$11.00+9.7%
    200-day average$13.38-9.9%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 57.0%.

    MeasureValue
    1-year beta0.90
    Largest fall, 1 year-57.0%
    Largest fall, 3 years-57.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About PHAR

    What is PHAR's 1-year price change?

    Pharming Group NV's price fell 28.3% over the past 12 months. With dividends included, the 12-month total return was -28.3%.

    What is PHAR's 5-year price change?

    Pharming Group NV's month-end price rose 35.9% over the 5 years through Oct 2026, a compound annual rate of 6.3%. These figures leave out dividends.

    What is PHAR's 52-week high and low?

    Pharming Group NV's 52-week high is $21.34 and its 52-week low is $9.11. Its latest price of $12.06 on Nov 17, 2026 is 43.5% below the high.

    What is PHAR's beta?

    Pharming Group NV's 1-year beta against the S&P 500 is 0.90, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 57.0%.

    Is the PHAR chart free?

    Yes. Advanced Charting for PHAR is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.